BioSpace News Archive

BioLife Solutions , Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced that the Company’s first quarter 2020 financial results will be released after market close on Thursday, May 14th, 2020 , and that

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the development of immunology based therapies for prevalent inflammatory conditions, today announced a manuscript accepted for publication in The Journal of Patient Safety in Surgery that showed Ampion treatment could improve clinical outcome

InMode Ltd., a leading global provider of innovative medical technologies, announced that management is scheduled to participate at the following virtual investor conferences:

TORONTO, May 11, 2020 /PRNewswire/ - Portage Biotech Inc., is pleased to announce that it has made an additional €900k investment in its associate, Stimunity, the Paris-based cancer immunotherapy company focused on STING.

Presentations will showcase data on the potential of gene circuits to precisely target cancer and new preclinical data on SENTI-101

Vasomune Therapeutics, Inc., a therapeutic biopharmaceutical company developing a novel first-in-class medicine for the treatment of COVID-19 pneumonia and pathogen-induced ARDS, today announced the formation of a Clinical and Scientific Advisory Board. The Board is composed of key opinion leaders in their respective fields of medicine and

Data on final analysis of overall survival (OS) from the Phase III ARAMIS trial investigating NUBEQA® (darolutamide) in men with non-metastatic castration-resistant prostate cancer (nmCRPC)

The LG Chem Life Sciences Innovation Center and LabCentral, today announced a Gold sponsorship agreement including a Golden Ticket which will be awarded to a select startup company in 2020.

Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, introduces the Slimplicity® HP Anterior Cervical Plating (ACP) System, which enables surgeons to accommodate diverse patient anatomies and pathologies with low profile constrained, semi-constrained or hybrid constructs.

A California appeals court reinstated the eligibility of thousands of claimant cases, reversing a lower court’s grant of Johnson & Johnson and its subsidiaries’ motion for summary judgment on federal preemption grounds. The decision allows affected Risperdal cases to proceed in the California coordinated proceeding after years of mot